Mc Kinley Carter Wealth Services, Inc. Gilead Sciences, Inc. Transaction History

Mc Kinley Carter Wealth Services, Inc.

$1.47 Billion
Q1 2024

A detailed history of Mc Kinley Carter Wealth Services, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mc Kinley Carter Wealth Services, Inc. holds 3,127 shares of GILD stock, worth $211,885. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,127

Previous 3,127 -0.0%

Holding current value

$211,885

Previous $253,000 9.49%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	SELL	$73.94 - $80.67 $38,892 - $42,432	-526 Reduced 14.4%	3,127 $234,000
Q1 2023 Apr 24, 2023	BUY	$77.31 - $88.08 $40,665 - $46,330	526 Added 16.82%	3,653 $303,000
Q4 2022 Feb 07, 2023	BUY	$62.32 - $89.47 $194,874 - $279,772	3,127 New	3,127 $268,000
Q1 2022 Apr 27, 2022	SELL	$57.92 - $72.58 $203,704 - $255,263	-3,517 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $16,219 - $18,410	-250 Reduced 6.64%	3,517 $255,000

Q3 2021 Nov 03, 2021	SELL	$67.69 - $73.03 $83,394 - $89,972	-1,232 Reduced 24.64%	3,767 $263,000
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $18,850 - $20,596	-297 Reduced 5.61%	4,999 $344,000
Q1 2021 Apr 30, 2021	SELL	$60.0 - $68.46 $76,860 - $87,697	-1,281 Reduced 19.48%	5,296 $343,000
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $1,529 - $1,742	27 Added 0.41%	6,577 $384,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $22,660 - $25,820	400 Added 6.5%	6,550 $382,000
Q3 2020 Oct 14, 2020	BUY	$62.1 - $78.08 $1,614 - $2,030	26 Added 0.42%	6,150 $389,000
Q2 2020 Jul 20, 2020	BUY	$72.34 - $84.0 $19,604 - $22,764	271 Added 4.63%	6,124 $471,000
Q1 2020 May 01, 2020	BUY	$62.63 - $80.22 $147,994 - $189,559	2,363 Added 67.71%	5,853 $438,000
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $13,064 - $14,421	-209 Reduced 5.65%	3,490 $221,000
Q2 2019 Aug 02, 2019	BUY	$61.87 - $69.38 $12,930 - $14,500	209 Added 5.99%	3,699 $250,000
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $9,202 - $12,008	-152 Reduced 4.17%	3,490 $218,000
Q3 2018 Nov 06, 2018	BUY	$71.28 - $78.92 $10,834 - $11,995	152 Added 4.36%	3,642 $281,000
Q2 2018 Dec 07, 2018	SELL	$64.88 - $75.68 $64,879 - $75,680	-1,000 Reduced 22.27%	3,490 $247,000
Q3 2017 Oct 31, 2017	SELL	$72.11 - $85.47 $18,388 - $21,794	-255 Reduced 5.37%	4,490 $364,000
Q2 2017 Aug 08, 2017	BUY	N/A	4,745	4,745 $336,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $84.9B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Kinley Carter Wealth Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mc Kinley Carter Wealth Services, Inc. with notifications on news.

Account

Mc Kinley Carter Wealth Services, Inc. Gilead Sciences, Inc. Transaction History